Marker Therapeutics Inc. (NASDAQ:MRKR) went up by 8.33% from its latest closing price compared to the recent 1-year high of $3.39. The company’s stock price has collected 23.81% of gains in the last five trading sessions. Press Release reported 16 hours ago that Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
Is It Worth Investing in Marker Therapeutics Inc. (NASDAQ :MRKR) Right Now?
Plus, the 36-month beta value for MRKR is at 1.29. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Marker Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $7.00. MRKR currently public float of 33.67M and currently shorts hold a 10.20% ratio of that float. Today, the average trading volume of MRKR was 360.94K shares.
MRKR’s Market Performance
MRKR stocks went up by 23.81% for the week, with a monthly jump of 26.06% and a quarterly performance of 25.30%, while its annual performance rate touched -35.20%. The volatility ratio for the week stands at 7.41% while the volatility levels for the past 30 days are set at 9.62% for Marker Therapeutics Inc.. The simple moving average for the period of the last 20 days is 29.43% for MRKR stocks with a simple moving average of 12.49% for the last 200 days.
Analysts’ Opinion of MRKR
Many brokerage firms have already submitted their reports for MRKR stocks, with Piper Sandler repeating the rating for MRKR by listing it as a “Neutral.” The predicted price for MRKR in the upcoming period, according to Piper Sandler is $2.50 based on the research report published on May 12th of the previous year 2020.
MRKR Trading at 32.48% from the 50-Day Moving Average
After a stumble in the market that brought MRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.64% of loss for the given period.
Volatility was left at 9.62%, however, over the last 30 days, the volatility rate increased by 7.41%, as shares surge +30.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +52.94% upper at present.
During the last 5 trading sessions, MRKR rose by +23.81%, which changed the moving average for the period of 200-days by +9.47% in comparison to the 20-day moving average, which settled at $1.63. In addition, Marker Therapeutics Inc. saw 43.45% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for MRKR
Current profitability levels for the company are sitting at:
- -10567.28 for the present operating margin
The net margin for Marker Therapeutics Inc. stands at -10050.92. The total capital return value is set at -43.36, while invested capital returns managed to touch -41.32. Equity return is now at value -56.30, with -49.40 for asset returns.
Based on Marker Therapeutics Inc. (MRKR), the company’s capital structure generated 1.10 points at debt to equity in total, while total debt to capital is 1.09. Total debt to assets is 1.04, with long-term debt to equity ratio resting at 0.64. Finally, the long-term debt to capital ratio is 0.63.
When we switch over and look at the enterprise to sales, we see a ratio of 412.17, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 2.59 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 22.83.